Alpha 2.0
Login Register
» Authors » Miguel Angel Rodriguez Weber

Miguel Angel Rodriguez Weber

Explore the profile of Miguel Angel Rodriguez Weber including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 116
Followers 0
Related Specialties
Infectious Diseases
Allergy & Immunology
Pediatrics
Top 10 Co-Authors
Rolando Ulloa-Gutierrez
Abiel Mascarenas De Los Santos
Terry Nolan
Angkool Kerdpanich
Sumita Roy-Ghanta
Idis Faingezicht
Ping Li
Pio Lopez
Eduardo Lazcano-Ponce
Aurelio Cruz-Valdez
Published In
Hum Vaccin Immunother
Salud Publica Mex
Clin Infect Dis
J Infect
J Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study
Faust S, Le Roy M, Pancharoen C, Weber M, Cathie K, Behre U, et al.
BMC Pediatr . 2019 Feb; 19(1):50. PMID: 30732648
Background: A new formulation of the live-attenuated varicella vaccine Varilrix (GSK) produced without human serum albumin (HSA) was developed to minimize a theoretical risk of transmission of infectious diseases. A...
2.
Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample
Taylor S, Lopez P, Weckx L, Borja-Tabora C, Ulloa-Gutierrez R, Lazcano-Ponce E, et al.
J Infect . 2016 Sep; 74(1):29-41. PMID: 27667752
Background: Better population data on respiratory viruses in children in tropical and southern hemisphere countries is needed. Methods: The epidemiology of respiratory viruses among healthy children (6 months to <10...
3.
Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial
Nolan T, Borja-Tabora C, Lopez P, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, et al.
Clin Infect Dis . 2015 Feb; 60(11):e80-9. PMID: 25673560
Background: The high burden of respiratory syncytial virus (RSV)-associated morbidity and mortality makes vaccine development a priority. Methods: As part of an efficacy trial of pandemic influenza vaccines (NCT01051661), RSV...
4.
Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial
Nolan T, Roy-Ghanta S, Montellano M, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, et al.
J Infect Dis . 2014 Mar; 210(4):545-57. PMID: 24652494
Background: The vaccine efficacy (VE) of 1 or 2 doses of AS03-adjuvanted influenza A(H1N1) vaccine relative to that of 2 doses of nonadjuvanted influenza A(H1N1) vaccine in children 6 months...
5.
A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age
Pavia-Ruz N, Weber M, Lau Y, Nelson E, Kerdpanich A, Huang L, et al.
Hum Vaccin Immunother . 2013 Jun; 9(9):1978-88. PMID: 23782962
The trivalent inactivated influenza vaccine Fluarix™ is licensed in the US for adults and children from 3 years old. This randomized observer-blind study (NCT00764790) evaluated Fluarix™ at two doses; 0.25...
6.
The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)
Rinderknecht S, Bryant K, Nolan T, Pavia-Ruz N, Aranza Doniz C, Weber M, et al.
Hum Vaccin Immunother . 2012 Feb; 8(3):304-11. PMID: 22327493
The safety profile of HibMenCY was compared with licensed Hib conjugate vaccines in a pooled analysis that included more than 8,500 subjects who were administered a four-dose series of HibMenCY...
7.
[Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention. Expert Group on Pertussis Vaccination]
Beltran Silva S, Cervantes Apolinar Y, Cherry J, Conde Gonzalez C, Gentile A, Altamirano C, et al.
Salud Publica Mex . 2011 Feb; 53(1):57-65. PMID: 21340141
Pertussis continues to be responsible for a significant disease burden worldwide. Although immunization practices have reduced the occurrence of the disease among children, waning vaccine- and infection-induced immunity still allows...